In Canada, between 3,000 and 4,000 people are living with amyotrophic lateral sclerosis (ALS), a disease that remains ...

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that causes the progressive loss of motor neurons, which in most cases leads to respiratory failure within three to five years after ...

The Department of Pathology is thrilled to announce a new faculty member joining our team January 1. Natalie R. Gassman, Ph.D., joins the Division of Molecular and Cellular Pathology, led by Rakesh ...

Researchers have developed a gene therapy that significantly slowed motor function loss in preclinical models of amyotrophic lateral sclerosis (ALS), offering new hope for treating the devastating ...

Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig’s disease, is a rare yet devastating neurological disorder that progressively weakens the body’s voluntary muscles. It occurs when ...

When the results of the first-ever platform trial for amyotrophic lateral sclerosis (ALS) were published this February, the headlines might have seemed disappointing: four experimental drugs failed to ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes the gradual loss of motor neurons in the brain and spinal cord, leading to muscle weakness, paralysis, and ...